The total value of deals for 2019 exceeds $30 billion.
Overall activity in deals jumped 11% in North America.
The order settles anti-competitive charges related to vascular closure devices.
Industry consolidation, consumerized medical devices and cybersecurity are the top issues in the year ahead.
Medical device companies have upped their game in product security and regulatory compliance, but they might not be ready for a catastrophic event.
Ernst & Young’s Pulse of the Industry report is out, and once again, it’s not all gloom and doom.
Acquisitions and joint ventures with Asian medical companies can provide many advantages for Western firms looking to grow their businesses in Asian medical device markets.
According to a regulatory filing dated January 12, Medtronic and Covidien could complete their $43 billion mega-merger by the end of the month.
Olivier Bohuon says he is not a fan of the concept of big is beautiful, and adds that there’s not much innovation occurring in hip implants.